Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

Por Kanters, Tim A., Stevanovic, Jelena, Huys, Isabelle, Vulto, Arnold G., Simoens, Steven
Publicado no Front Pharmacol (2017)

Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart Disease

Por Stevanović, Jelena, Pechlivanoglou, Petros, Kampinga, Marthe A., Krabbe, Paul F. M., Postma, Maarten J.
Publicado no PLoS One (2016)

Number of decidual natural killer cells & macrophages in pre-eclampsia

Por Milosevic-Stevanovic, Jelena, Krstic, Miljan, Radovic-Janosevic, Dragana, Popovic, Jasmina, Tasic, Marija, Stojnev, Slavica
Publicado no Indian J Med Res (2016)

Serum Level of HMGB1 Protein and Inflammatory Markers in Patients with Secondary Peritonitis: Time Course and the Association with Clinical Status

Por Milić, Ljiljana, Grigorov, Ilijana, Krstić, Slobodan, Ćeranić, Miljan S., Jovanović, Bojan, Stevanović, Jelena, Peško, Predrag
Publicado no J Med Biochem (2017)

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands

Por Stevanović, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Publicado em 2014

Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data

Por van Leent, Merlijn W. J., Stevanović, Jelena, Jansman, Frank G., Beinema, Maarten J., Brouwers, Jacobus R. B. J., Postma, Maarten J.
Publicado no PLoS One (2015)